Company Filing History:
Years Active: 1997-2001
Title: Innovative Contributions of Shintaro Suzuki
Introduction:
Shintaro Suzuki is a prominent inventor based in Torrance, California, who has made significant strides in the field of biomedical engineering. With a total of nine patents to his name, Suzuki's work primarily focuses on novel polypeptides and their applications in the field of antibody production.
Latest Patents:
Among his latest innovations, he has developed methods for antagonizing the binding of protocadherin-42, which include polynucleotide sequences encoding novel cadherin-like polypeptides. These innovations provide methods and materials for the recombinant production of these polypeptides, as well as antibody substances that are specific for protocadherins. Additionally, he has also patented sequences related to human protocadherin-43, aiming to enhance the modulation of natural binding activities of these proteins.
Career Highlights:
Shintaro Suzuki currently works at the Doheny Eye Institute, an organization well-regarded for its research and contributions to ophthalmology. His expertise has not only advanced scientific knowledge but has also paved the way for new therapeutic applications.
Collaborations:
Throughout his career, Suzuki has likely partnered with various research institutions and companies, although specific collaborations are not detailed. His role at the Doheny Eye Institute suggests a potential for extensive networking and partnership within the medical and scientific community.
Conclusion:
Shintaro Suzuki's dedication to innovation is evident through his impressive portfolio of patents. His work in developing novel methods and polypeptides showcases his commitment to advancing biomedical science, making significant contributions to the field that may lead to improved therapeutic strategies.